Biologics company Cryosite has denied claims by the ACCC that it engaged in cartel conduct by referring customers to Cell Care before their asset sale agreement was completed, saying the two were not competitors.
Sirtex buyout sparks insolvency fears by class action
Concerns that the proposed acquisition of Sirtex Medical by a Chinese private equity firm would leave the company with insufficient funds to cover a settlement or judgement in a class action were eased Wednesday, after a barrister said the takeover would leave the company with just under $1 billion in assets.